The National Institutes of Health (NIH) recently announced a new policy for indirect cost reimbursement for research grants that would cap all new and existing grants at 15%, a significant reduction. Indirect costs are expenses that support essential infrastructure and administrative functions of research institutions, such as facility maintenance, utilities, and administrative staff. 

Currently, indirect costs vary by institution, but the average rate for NIH grants is between 29% - 39%. Some of the largest and most sophisticated institutions have an indirect cost rate of over 60%. An indirect cost reduction to 15% across the board will have a significant impact on existing and prospective research, with research institutions scaling back or potentially closing labs.

Scientific breakthroughs are happening, and we need to ensure they continue – new treatments, therapies, and diagnostics for gynecologic cancer patients are imperative. Please take action today and let the administration know you want to ensure critical cancer research continues at the highest level possible.